Opinion: Biopharmaceuticals - filling the gaps in Australia's capabilities
Tuesday, August 5, 2008 - 12:36
in Mathematics & Economics
Developments in pre-clinical manufacture and scale-up, pre-clinical and toxicology testing, and in the design and running of clinical trials, mean the main gaps have been filled in Australia’s development chain for new biopharmaceuticals, writes Peter Gray.